Canada markets closed

Tryp Therapeutics Inc. (8FW.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0285+0.0010 (+3.64%)
At close: 08:10AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-08-31
2022-08-31
2021-08-31
2020-08-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
1,669
2,356
2,964
1,281
8.327
Selling General and Administrative
2,389
2,368
4,400
6,007
414.29
Total Operating Expenses
4,059
4,724
7,364
7,288
422.617
Operating Income or Loss
-4,059
-4,724
-7,364
-7,288
-422.617
Total Other Income/Expenses Net
-36.141
-22.417
-134.149
-977.533
-
Income Before Tax
-4,793
-5,267
-7,495
-8,255
-422.617
Income from Continuing Operations
-4,793
-5,267
-7,495
-8,255
-422.617
Net Income
-4,793
-5,267
-7,495
-8,255
-422.617
Net Income available to common shareholders
-4,793
-5,267
-7,495
-8,255
-422.617
Basic EPS
-0.07
-0.05
-0.10
-0.14
-0.01
Diluted EPS
-0.07
-0.05
-0.10
-0.14
-0.01
Basic Average Shares
96,382
96,419
78,065
57,512
66,320
Diluted Average Shares
96,382
96,419
78,065
57,512
66,320